DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,183,543 | -25.4% | 57,370 | +6.7% | 0.01% | -16.7% |
| Q2 2023 | $1,587,225 | +22.5% | 53,786 | -4.4% | 0.01% | +9.1% |
| Q1 2023 | $1,295,861 | -28.0% | 56,244 | -13.1% | 0.01% | -31.2% |
| Q4 2022 | $1,799,057 | +16.2% | 64,691 | +28.3% | 0.02% | +14.3% |
| Q3 2022 | $1,548,000 | -13.8% | 50,435 | -17.3% | 0.01% | 0.0% |
| Q2 2022 | $1,795,000 | +2.5% | 61,007 | +12.1% | 0.01% | +27.3% |
| Q1 2022 | $1,751,000 | -16.4% | 54,427 | +15.8% | 0.01% | 0.0% |
| Q4 2021 | $2,095,000 | – | 46,982 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |